Abridge secures $250M for core research and development
Abridge, a generative AI platform for clinical conversations, announced it raised a $250 million Series D investment. The round was co-led by Elad Gil and IVP, with participation from Bessemer…
- Wed. Sep 23rd, 2026
Driving Technological Innovation